SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: richard davis who wrote (1071)12/13/1996 9:24:00 PM
From: Nikole Wollerstein   of 4342
 
I bought PRLN after the presentation in San Francisco this spring, and I had an impression probably from something that have been said, that Rhodes planning to step down in near future When Co will have solid financial support. He still hold 711 Th. shares. By the way they did not talk about cure on this presentation. They talked about cost-effective cancer management.
I also like Androvir numbers released yesterday. Do not forget: it is the first trial,
orally, not toxic, for $1000/year, it will be first product on the market
from Chinese collection through "signal transduction technology" to the shelf a dream come ...
It can make all the difference in the cocktail. Nikita
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext